Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.28 HKD
4.48 B HKD
83.06 B HKD
219.90 M
About GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED
Sector
CEO
Hong Li
Headquarters
Guangzhou
Website
Founded
1997
ISIN
CNE100000387
FIGI
BBG000BMHD83
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern Traditional Chinese Medicine (TCM), Great Health, Great Commerce, and Other. The Great Southern TCM segment provides research, development, manufacturing, and sales for Chinese and Western medicine. The Great Health segment refers to the research, development, manufacturing, and sales for the products of Great Health. The Great Commerce segment relates to the wholesale, retail, import, and export for Western medicine, Chinese medicine, and medical apparatus and instruments. The Other segment is involved in other manufacturing and distributing traditional Chinese medicines activities. The company was founded on September 1, 1997 and is headquartered in Guangzhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 874 is 18.20 HKD — it has increased by 0.44% in the past 24 hours. Watch GUANGZHOU BAIYUNSHAN PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange GUANGZHOU BAIYUNSHAN PHARMACEUTICAL stocks are traded under the ticker 874.
874 stock has risen by 0.66% compared to the previous week, the month change is a 0.66% rise, over the last year GUANGZHOU BAIYUNSHAN PHARMACEUTICAL has showed a −11.86% decrease.
We've gathered analysts' opinions on GUANGZHOU BAIYUNSHAN PHARMACEUTICAL future price: according to them, 874 price has a max estimate of 25.39 HKD and a min estimate of 20.90 HKD. Watch 874 chart and read a more detailed GUANGZHOU BAIYUNSHAN PHARMACEUTICAL stock forecast: see what analysts think of GUANGZHOU BAIYUNSHAN PHARMACEUTICAL and suggest that you do with its stocks.
874 stock is 1.11% volatile and has beta coefficient of 0.79. Track GUANGZHOU BAIYUNSHAN PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is GUANGZHOU BAIYUNSHAN PHARMACEUTICAL there?
Today GUANGZHOU BAIYUNSHAN PHARMACEUTICAL has the market capitalization of 29.59 B, it has increased by 0.19% over the last week.
Yes, you can track GUANGZHOU BAIYUNSHAN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL is going to release the next earnings report on Mar 17, 2025. Keep track of upcoming events with our Earnings Calendar.
874 earnings for the last quarter are 0.41 HKD per share, whereas the estimation was 0.50 HKD resulting in a −17.78% surprise. The estimated earnings for the next quarter are 0.32 HKD per share. See more details about GUANGZHOU BAIYUNSHAN PHARMACEUTICAL earnings.
874 net income for the last quarter is 663.13 M HKD, while the quarter before that showed 638.44 M HKD of net income which accounts for 3.87% change. Track more GUANGZHOU BAIYUNSHAN PHARMACEUTICAL financial stats to get the full picture.
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL dividend yield was 3.78% in 2023, and payout ratio reached 29.85%. The year before the numbers were 3.53% and 28.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 28.05 K employees. See our rating of the largest employees — is GUANGZHOU BAIYUNSHAN PHARMACEUTICAL on this list?
Like other stocks, 874 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GUANGZHOU BAIYUNSHAN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GUANGZHOU BAIYUNSHAN PHARMACEUTICAL technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GUANGZHOU BAIYUNSHAN PHARMACEUTICAL stock shows the sell signal. See more of GUANGZHOU BAIYUNSHAN PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.